← FDA Drug Approvals (Drugs@FDA)
ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA · Approved 2017-05-19
Drug application
- FDA Application #
ANDA077337- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ROSIGLITAZONE MALEATE AND METFORMIN HYDROCHLORIDE
- Generic name
- Metformin Hydrochloride
- Active ingredients
- METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TEVA
- First approval
- 2017-05-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown